Desmoplastic melanoma: Demographic and clinicopathological features and disease‑specific prognostic factors

Shi,Ping; Xu,Zhe; Lei,Xin; Yibulayin,Feiluore; Wushou,Alimujiang

doi:10.3892/ol.2019.10259

Desmoplastic melanoma: Demographic and clinicopathological features and disease‑specific prognostic factors

Authors:
- Ping Shi
- Zhe Xu
- Xin Lei
- Feiluore Yibulayin
- Alimujiang Wushou
View Affiliations

Affiliations: Department of Stomatology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong 518110, P.R. China, Department of Preventive Medicine, School of Public Health, Fudan University, Shanghai 200001, P.R. China, Department of Oral and Maxillofacial Surgery, Shanghai Stomatological Hospital, Fudan University, Shanghai 200001, P.R. China
Published online on: April 17, 2019 https://doi.org/10.3892/ol.2019.10259
Pages: 5619-5627
Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Desmoplastic melanoma (DM) is a rare morphological subtype of melanoma that remains uncharacterized. The aim of the present study was to investigate the incidence of DM, its general demographics, clinicopathological features and disease‑specific prognostic factors. DM cases were sampled from the Surveillance, Epidemiology and End Results (SEER) program from between 1973 and 2017. A total of 3,657 cases (median age, 68 years) were identified. The results indicated that DM primarily occurred in Caucasian subjects, with a male‑to‑female ratio of 2:1. Statistically significant overall survival (OS) and disease‑specific survival (DSS) rate differences were identified according to sex, age, treatment, T stage, N stage and SEER historic tumor stage (P<0.05). In multivariate Cox regression analysis, age >68 years, male sex, American Joint Committee on Cancer (AJCC) stage II and III, and SEER historic tumor stage of the regional tumor were all factors associated with poorer OS and DSS rates. The findings also revealed that surgical treatment was associated with favorable DSS and OS rates. In conclusion, DM occurred primarily in Caucasian subjects of 60‑80 years of age, with predominance in males. Furthermore, age, sex, AJCC stage, SEER historic tumor stage and surgical treatment were identified as independent prognostic factors of DM in terms of DSS and OS.

View Figures

View References

1	Conley J, Lattes R and Orr W: Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 28:914–936. 1971. View Article : Google Scholar : PubMed/NCBI
2	Weissinger SE, Keil P, Silvers DN, Klaus BM, Möller P, Horst BA and Lennerz JK: A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma. Mod Pathol. 27:524–534. 2014. View Article : Google Scholar : PubMed/NCBI
3	Magro CM, Crowson AN and Mihm MC: Unusual variants of malignant melanoma. Mod Pathol. 19 (Suppl 2):S41–S70. 2006. View Article : Google Scholar : PubMed/NCBI
4	Reed RJ and Leonard DD: Neurotropic melanoma. A variant of desmoplastic melanoma. Am J Surg Pathol. 3:301–311. 1979. View Article : Google Scholar : PubMed/NCBI
5	Manfredini M, Pellacani G, Losi L, Maccaferri M, Tomasi A and Ponti G: Desmoplastic melanoma: A challenge for the oncologist. Future Oncol. 13:337–345. 2017. View Article : Google Scholar : PubMed/NCBI
6	Wasif N, Gray RJ and Pockaj BA: Desmoplastic melanoma-the step-child in the melanoma family? J Surg Oncol. 103:158–162. 2011. View Article : Google Scholar : PubMed/NCBI
7	Mărgăritescu I and Chiriţă AD: Desmoplastic melanoma-challenges in the diagnosis and management of a rare cutaneous tumor. Rom J Morphol Embryol. 55:947–952. 2014.PubMed/NCBI
8	Pace CS, Kapil JP, Wolfe LG, Kaplan BJ and Neifeld JP: Desmoplastic melanoma: Clinical behavior and management implications. Eplasty. 16:e32016.PubMed/NCBI
9	Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS and Seigler HF: Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Ann Surg Oncol. 13:728–739. 2006. View Article : Google Scholar : PubMed/NCBI
10	Lens MB, Newton-Bishop JA and Boon AP: Desmoplastic malignant melanoma: A systematic review. Br J Dermatol. 152:673–678. 2005. View Article : Google Scholar : PubMed/NCBI
11	Oliver DE, Patel KR, Switchenko J, Parker D, Lawson DH, Delman KA, Kudchadkar RR and Khan MK: Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Res. 26:35–41. 2016. View Article : Google Scholar : PubMed/NCBI
12	Khan F, Strohl A, Allen PD and Doerr TD: Desmoplastic melanoma of the head and neck: Incidence and survival, 1992–2013. Otolaryngol Head Neck Surg. 157:648–656. 2017. View Article : Google Scholar : PubMed/NCBI
13	Feng Z, Wu X, Chen V, Velie E and Zhang Z: Incidence and survival of desmoplastic melanoma in the United States, 1992–2007. J Cutan Pathol. 38:616–624. 2011. View Article : Google Scholar : PubMed/NCBI
14	Han D, Han G, Zhao X, Rao NG, Messina JL, Marzban SS, Sarnaik AA, Cruse CW, Sondak VK and Zager JS: Clinicopathologic predictors of survival in patients with desmoplastic melanoma. PLoS One. 10:e01197162015. View Article : Google Scholar : PubMed/NCBI
15	Fritz A, Percy C, Jack A, Shanmugarathan S, Sobin L, Parkin DM and Whelan S: International classification of diseases for oncology (ICD-O-3). World Health Organization; 2000
16	Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
17	Machado I, Llombart B, Cruz J, Traves V, Requena C, Nagore E, Parafioriti A, Monteagudo C and Llombart-Bosch A: Desmoplastic melanoma may mimic a cutaneous peripheral nerve sheath tumor: Report of 3 challenging cases. J Cutan Pathol. 44:632–638. 2017. View Article : Google Scholar : PubMed/NCBI
18	Plaza JA, Bonneau P, Prieto V, Sangueza M, Mackinnon A, Suster D, Bacchi C, Estrozi B, Kazakov D, Kacerovska D, et al: Desmoplastic melanoma: An updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis. J Cutan Pathol. 43:313–323. 2016. View Article : Google Scholar : PubMed/NCBI
19	Maher NG, Solinas A, Scolyer RA, Puig S, Pellacani G and Guitera P: Detection of desmoplastic melanoma with dermoscopy and reflectance confocal microscopy. J Eur Acad Dermatol Venereol. 31:2016–2024. 2017. View Article : Google Scholar : PubMed/NCBI
20	Lawrence NF, Hammond MR, Frederick DT, Su Y, Dias-Santagata D, Deng A, Selim MA, Mahalingam M, Flaherty KT and Hoang MP: Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. J Am Acad Dermatol. 75:595–602. 2016. View Article : Google Scholar : PubMed/NCBI
21	Lorcy S, Koeppel MC, Richard MA, Grob JJ, Berbis P and Morand JJ: Desmoplastic melanoma: a study of 23 cases at 3 centres in the Bouches-du-Rhone region. Ann Dermatol Venereol. 141:656–662. 2014. View Article : Google Scholar : PubMed/NCBI
22	Murali R, Zannino D, Synnott M, McCarthy SW, Thompson JF and Scolyer RA: Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma. Histopathology. 58:886–895. 2011. View Article : Google Scholar : PubMed/NCBI
23	Sims JR, Wieland CN, Kasperbauer JL, Moore EJ and Price DL: Head and neck desmoplastic melanoma: Utility of sentinel node biopsy. Am J Otolaryngol. 38:537–541. 2017. View Article : Google Scholar : PubMed/NCBI
24	Mohebati A, Ganly I, Busam KJ, Coit D, Kraus DH, Shah JP and Patel SG: The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma. Ann Surg Oncol. 19:4307–4313. 2012. View Article : Google Scholar : PubMed/NCBI
25	Murali R, Shaw HM, Lai K, McCarthy SW, Quinn MJ, Stretch JR, Thompson JF and Scolyer RA: Prognostic factors in cutaneous desmoplastic melanoma: A study of 252 patients. Cancer. 116:4130–4138. 2010. View Article : Google Scholar : PubMed/NCBI
26	Egger ME, Huber KM, Dunki-Jacobs EM, Quillo AR, Scoggins CR, Martin RC II, Stromberg AJ, McMasters KM and Callender GG: Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma. J Am Coll Surg. 217:37–45. 2013. View Article : Google Scholar : PubMed/NCBI
27	Broer PN, Walker ME, Goldberg C, Buonocore S, Braddock DT, Lazova R, Narayan D and Ariyan S: Desmoplastic melanoma: A 12-year experience with sentinel lymph node biopsy. Eur J Surg Oncol. 39:681–685. 2013. View Article : Google Scholar : PubMed/NCBI
28	Dunne JA, Wormald JC, Steele J, Woods E, Odili J and Powell BW: Is sentinel lymph node biopsy warranted for desmoplastic melanoma? A systematic review. J Plast Reconstr Aesthet Surg. 70:274–280. 2017. View Article : Google Scholar : PubMed/NCBI
29	Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN and Gershenwald JE: Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 106:900–906. 2006. View Article : Google Scholar : PubMed/NCBI
30	Busam KJ, Mujumdar U, Hummer AJ, Nobrega J, Hawkins WG, Coit DG and Brady MS: Cutaneous desmoplastic melanoma: Reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 28:1518–1525. 2004. View Article : Google Scholar : PubMed/NCBI
31	Jaroszewski DE, Pockaj BA, DiCaudo DJ and Bite U: The clinical behavior of desmoplastic melanoma. Am J Surg. 182:590–595. 2001. View Article : Google Scholar : PubMed/NCBI
32	Trayanova E, Chokoeva AA, Patterson JW, Wollina U, Lotti T and Tchernev G: Desmoplastic malignant melanoma associated with pigmented ocular tumor: Second documented problematic case from the board of adcrstr-association for dermatohistopathologic control, re-evaluation and subsequent therapeutic recommendations. J Biol Regul Homeost Agents 29 (1 Suppl). S59–S64. 2015.
33	Maurichi A, Miceli R, Camerini T, Contiero P, Patuzzo R, Tragni G, Crippa F, Romanidis K, Ruggeri R, Carbone A and Santinami M: Pure desmoplastic melanoma: A melanoma with distinctive clinical behavior. Ann Surg. 252:1052–1057. 2010. View Article : Google Scholar : PubMed/NCBI